glp 1 and perimenopause Are you navigating menopause while considering GLP-1 treatments? You're not alone in having questions. With so much conflicting information out there, it's crucial to distinguish between myths evidence-based facts. From hormone A thoughtful approach to GLP-1
Description
The modified peptide contains 2 Aib substitutions at positions 2 and 20 with a molecular weight of 4.5 kDa
These drugs were first approved in diabetes under brand names Ozempic and Mounjaro, respectively

Glucagon-like peptide 1 and its cleavage products are renoprotective in murine diabetic nephropathy

Case study I am 58, obese (BMI 35), with pre-diabetes (borderline Type 2), hypothyroidism (on 50 microg thyroxine), high cholesterol, and multiple sclerosis
doi: 10.1124/jpet.121.000567, PMID: [DOI] [PubMed] [Google Scholar] 73

Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects
